July 2017 Vol XLI Issue 7
FRONTIERS IN ENDOSCOPY, SERIES #37Melanoma Metastatic to the Ampulla of Vater Diagnosed via EUS-Guided Core Biopsy
In this article, we discuss a rare presentation of metastatic melanoma to the ampulla where an endoscopy and endoscopic ultrasound were vital in evaluating the patient and obtaining core biopsies of the lesion. Proper tissue acquisition was made possible with EUS-FNB for pathology interpretation, showing the value of this technique.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #165Reinfusion of Gastrointestinal Secretions - The Bedside Experience
Both pancreatic enzymes and bile salts are necessary for complete absorption of dietary fat. While pancreatic enzymes are available to replace insufficient pancreatic secretion, there is no replacement for bile salts. Unabated external loss of upper intestinal secretions can result in dehydration, acid/base imbalance, electrolyte abnormalities as well as malabsorption. This article describes the reinfusion of GI secretions, various methods of reinfusion, as well as potential and significant pitfalls when embarking on this form of treatment.
DISPATCHES FROM THE GUILD CONFERENCE, SERIES #6Antiviral Therapy for Patients with Immune Active Hepatitis B - What, When and is Forever?
Hepatitis B is the most common chronic viral infection in the world and leads to significant complications. Antiviral therapies currently available are highly effective in achieving viral suppression, however if and when providers can consider discontinuation of antiviral therapy continue to evolve. Increasingly, there is emphasis on treating until HBsAg loss occurs, but this means many patients will be on life-long therapy. A finite duration of therapy is attractive to patients and providers but one must consider the potential risks when stopping treatment. New data continue to inform this question and are reflected in this review.
A CASE REPORTInternal Biliary Fistula Secondary to Cushing's Ulcer in a Child
ARIES PHARMACEUTICALS, INC. LAUNCHES ELEVIEW™ FOR USE IN GASTROINTESTINAL ENDOSCOPIC PROCEDURES
Novel Development in Submucosal Injection Agents Elevates Lesions to Facilitate Removal
SAN DIEGO - Aries Pharmaceuticals, Inc. (Aries) has announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable composition for use in the easy and safe endoscopic removal of polyps, adenomas, and early stage cancers, and other lesions in the gastrointestinal (GI) tract.
HYPER-IMPLANTETM, REPLENISS®, FORTEFYTM & FLORA-ELITE®
Probiotic Dietary Supplements from InterPlexus, Inc.
Probiotic and synbiotic supplements from InterPlexus, Inc. provide commensal flora to support gastrointestinal, dermatological, and immune systemhealth.* Multiple strains are combined in each product to re-inoculate with new colonies as well as maintain current healthy colonies of intestinal flora.
July 22, 2017 Mastering Clinical Challenges and Emerging Therapies in IBD
October 13-18, 2017 World Congress of Gastroenterology (WCOG) at ACG 2017
November 9-11, 2017 - Advances in Inflammatory Bowel Diseases - Multidisciplinary Approaches to IBD Patient - Centered Care New Presenters, New Content, A New Year